Dr. Ram Prabhu Balasubramanian, MD

Dr. Balasubramanian practices at Nebraska Heart Institute in Lincoln, Nebraska.

Dr. Balasubramanian's NPI, 1831346006, was assigned on August 19, 2008. Dr. Balasubramanian holds Florida license ME112004.

Dr. Balasubramanian's primary practice is Nebraska Heart Institute, at 7440 S 91st St, Lincoln, NE 68526 in Lancaster County. The practice phone is (402) 489-6555.

Dr. Balasubramanian's primary practice is Nebraska Heart Institute in Lincoln, Nebraska. Dr. Balasubramanian is also affiliated with CHI Health St. Elizabeth. The medical group on file is CHI Health Clinic Heart Institute (Lincoln - Nebraska Heart). Dmand AI also links Dr. Balasubramanian to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Balasubramanian practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Balasubramanian's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Balasubramanian is licensed in Florida.

CMS data shows 3,561 Medicare services from Dr. Balasubramanian across 29 procedure codes in 2024, for 1,323 Medicare patients. Medicare paid $165,914 for them.

CMS counts 1,323 Medicare patients who saw Dr. Balasubramanian in 2024. The largest group is 65 to 74, with 513 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Balasubramanian's median patient age at 69, with 43% women.

In 2024, Dr. Balasubramanian wrote 4,352 Medicare Part D claims for 626 patients. 80% of them were for generic drugs. CMS names the drug for 4,209 of them, across 44 drugs with 11 or more claims each, at $790,957 in total drug cost. In 2023, CMS named 971 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 17 out of 100 for Dr. Balasubramanian for performance year 2024, reported individually. Dr. Balasubramanian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 22 procedures of coronary angioplasty and stenting by Dr. Balasubramanian, more than 53% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Balasubramanian, published from 2016 to 2017. The most frequent topics are Electrocardiography and Myocardial Infarction. Dr. Balasubramanian's most frequent co-authors are Vinod Namana, Gerald Hollander, MD and Adnan Sadiq, MD.

CMS Open Payments shows 162 general payments to Dr. Balasubramanian from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 72% of the total. Medtronic Vascular, Inc. paid the most, $1,933.